In humans, SHH haploinsufficiency results in holoprosencephaly (HPE), a defect in anterior midline formation 1, 2 . Despite the importance of maintaining SHH transcript levels above a critical threshold, we know little about the upstream regulators of SHH expression in the forebrain. Here we describe a rare nucleotide variant located 460 kb upstream of SHH in an individual with HPE that resulted in the loss of Shh brain enhancer-2 (SBE2) activity in the hypothalamus of transgenic mouse embryos. Using a DNA affinity-capture assay, we screened the SBE2 sequence for DNA-binding proteins and identified members of the Six3 and Six6 homeodomain family as candidate regulators of Shh transcription. Six3 showed reduced binding affinity for the mutant compared to the wild-type SBE2 sequence. Moreover, Six3 with HPE-causing alterations failed to bind and activate SBE2. These data suggest a direct link between Six3 and Shh regulation during normal forebrain development and in the pathogenesis of HPE.
In humans, SHH haploinsufficiency results in holoprosencephaly (HPE), a defect in anterior midline formation 1, 2 . Despite the importance of maintaining SHH transcript levels above a critical threshold, we know little about the upstream regulators of SHH expression in the forebrain. Here we describe a rare nucleotide variant located 460 kb upstream of SHH in an individual with HPE that resulted in the loss of Shh brain enhancer-2 (SBE2) activity in the hypothalamus of transgenic mouse embryos. Using a DNA affinity-capture assay, we screened the SBE2 sequence for DNA-binding proteins and identified members of the Six3 and Six6 homeodomain family as candidate regulators of Shh transcription. Six3 showed reduced binding affinity for the mutant compared to the wild-type SBE2 sequence. Moreover, Six3 with HPE-causing alterations failed to bind and activate SBE2. These data suggest a direct link between Six3 and Shh regulation during normal forebrain development and in the pathogenesis of HPE.
Shh expression must be regulated in a temporally and spatially restricted manner in order for it to fulfill its multiple functions during forebrain and craniofacial development (reviewed in refs. 3, 4) . Three tissues, including the prechordal plate, ventral forebrain and facial ectoderm, have been identified as critical sources of Shh that promote distinct aspects of ventral forebrain and craniofacial morphogenesis [5] [6] [7] [8] . Interference with Shh signaling from any of these sites results in HPE, a spectrum of brain and craniofacial malformations, the severity of which correlates with the timing of Shh perturbation 6, 9, 10 . In humans, SHH haploinsufficiency is the predominant cause of HPE, indicating that the level of SHH expression is important for proper forebrain and craniofacial development 1 . Several downstream effectors of the SHH and NODAL signaling pathways have also been identified as targets of mutation in HPE, whereas mutations in SIX3 cause HPE through poorly defined mechanisms 2 . Although much is known about the signal transduction pathway functioning downstream of Shh, relatively little is known of the genes acting upstream in the pathway regulating Shh transcription in key signaling centers mediating forebrain and craniofacial development.
Previous efforts to address this issue have focused on determining the genomic location of functional Shh regulatory elements 11 . These experiments have identified six enhancers distributed over a 500-kb interval surrounding the Shh gene that directed reporter activity to most areas of Shh expression in the mouse central nervous system, including the ventral forebrain (Fig. 1a) . In particular, the highly conserved Shh brain enhancer-2 (SBE2), located 460 kb upstream of the SHH coding sequence, has been identified as unique in its ability to regulate Shh-like expression throughout the hypothalamus.
To identify functionally relevant nucleotides in SBE2, we screened the 1.1-kb sequence for mutations in humans with HPE. We reasoned that HPE-associated variants in SBE2 could aid in identifying critical cis and trans determinants of SHH expression in the forebrain. By analyzing 474 individuals with HPE, we identified one individual who was heterozygous for a cytosine to thymine base change at nucleotide position 444 (g.444C4T) of the enhancer sequence (human chr7:155,754,267; NCBI build 36.3). The C/T variant is situated within a block of 10 nucleotides that have been maintained in human, mouse, chicken and frog for over 350 million years (Fig. 1a) . We did not observe this C/T nucleotide variant in DNA samples from 450 unrelated control individuals. The affected female showed features of semilobar HPE including microcephaly, midfacial hypoplasia, cleftlip and palate, diabetes insipidus and moderate fusion of the hypothalamus and basal ganglia. The parents' genotype revealed that the father is an unaffected carrier, and the mother is homozygous for the wild-type SBE2(C) allele. It is known that approximately 30% of individuals heterozygous for loss-of-function mutations in SHH show no evidence of HPE 12 ; that is, these mutations are often nonpenetrant.
Thus, the finding that the carrier father is unaffected does not discount the possibility that SBE2(T) confers an increased risk of HPE. As mutations in known HPE-associated genes were not detected in the affected female, we sought to determine whether the singlenucleotide change could alter SBE2 activity and thus provide a molecular basis for her phenotype.
We tested human SBE2 sequences containing either the wild-type SBE2(C) or variant SBE2(T) residue for their ability to drive lacZ expression in transgenic mouse embryos. Embryos carrying the wildtype SBE2(C) reporter construct showed little variability in the spatial distribution of X-gal staining, recapitulating Shh expression in the hypothalamus from the mammillary region caudally to the preoptic area rostrally (n ¼ 8 of 9; Fig. 1b ,e,h,k). In contrast, embryos carrying SBE2(T) consistently showed a loss of reporter activity from the level of the optic vesicles to the rostral extent of the diencephalon (n ¼ 10 of 11; Fig. 1c ,f,i,l). The reduction in SBE2 reporter activity was similar in embryos carrying SBE2(D), a construct in which the highly conserved 10-bp sequence overlapping the C/T substitution was deleted (n ¼ 5 of 6; Fig. 1d,g,j,m) . Notably, the area of the ventral diencephalon that showed decreased X-gal staining in embryos carrying SBE2(T) correlated with the sites of malformation shown by the individual with HPE. The anterior region of the ventral diencephalon is an important source of Shh for the development of the face and pituitary gland 10, 13, 14 .
On the basis of these findings, we hypothesized that the conserved 10-bp SBE2 sequence serves as a binding site for a transcriptional regulator whose function is required for the activation of Shh expression in the anteroventral portion of the hypothalamus. In the presence of the SBE2(T) variant, assembly of this transcriptional activation complex is compromised, likely resulting in the reduction of Shh expression below a critical threshold. The analysis of the 10-bp sequence in question did not reveal informative transcription factor binding sites in the TRANSFAC database (see URLs section in Methods). Therefore, we sought to identify the putative SBE2-binding protein using a DNA affinity-capture assay 15 .
We first incubated a biotinylated 18-bp double-stranded SBE2 probe with nuclear extracts prepared from adult mouse brain. Next, Note that in addition to the supershift, incubation with the antibody to Flag also disrupted Six3/Six6-SBE2 and Six3/Six6-WEE complex formation (lanes 4, 7, 11, 13, 15, 17) . The asterisk indicates the formation of a nonspecific complex that is more effectively competed away in the presence of Six3 and Six6 and high-affinity probes.
we pulled down DNA-protein complexes with streptavidin-coated agarose beads and analyzed their protein content by mass spectrometry (see Methods). To control for nonspecific DNA-binding proteins, we compared SBE2-extracted proteins to those pulled down with an SBE2 probe containing multiple nucleotide mismatches in highly conserved residues. Only DNA-binding proteins specific for SBE2 were considered further. Of the six transcription factors identified (Supplementary Table 1 online), the one of greatest interest was Six6, a homeodomain-containing protein belonging to the optix family of transcriptional regulators that includes Six3, a protein implicated in HPE 16, 17 .
To validate the binding of Six3 and Six6 proteins to SBE2, we carried out electrophoretic mobility shift assays (EMSAs). COS-1 cell lysates transfected with Flag-tagged versions of full-length Six3 and Six6 formed specific complexes when incubated with a radiolabeled SBE2(C) probe (Fig. 2, lanes 1,3,6 ). These protein-DNA complexes were supershifted when exposed to an antibody to Flag (a-Flag) ( Specific complexes formed with similar mobility when we used an SBE2(T) probe; however, the intensity of the bands was noticeably weaker (Fig. 2 , lanes 9-13). We also observed similar protein-DNA 5) were more efficient at displacing radiolabeled SBE2(C) probe from Six3, compared to increasing concentrations of cold SBE2(T) competitor (lanes [6] [7] [8] . A nonspecific probe (lane 9) did not significantly alter the shifted complex. C, control. (d) Graphical representation of the data in c. The relative intensities of the retarded bands were quantified and plotted against competitor concentration. Each data point on the curve is an average of five independent experiments. At subsaturating concentrations of competitor (50Â, 100Â), SBE2(C) (black line) was significantly more effective at interfering with complex formation than SBE2(T) (gray line) (*P o 0.05, Student's t-test). (e) ChIP from embryos using antibodies to Six3 or IgG. QPCR results from three independent experiments reveal a significant enrichment of SBE2 DNA in Six3-versus IgG-bound chromatin isolated from forebrain but not posterior trunk regions of E8.75 mouse embryos (*P o 0.01, Student's t-test). A negative control sequence, 6.5 kb downstream of SBE2, was not enriched in Six3-bound chromatin, whereas a positive control sequence, Pax6 SIMO, was enriched to a similar degree as SBE2. Error bars, s.d. 
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complexes using a probe overlapping a Wnt1 enhancer element (WEE) that was previously shown to contain a consensus Six3 binding motif 18, 19 (Fig. 2, lanes 14-17) . These results confirm the existence of a unique Six3 and Six6 binding site in SBE2.
Six3 and Six6 show dynamic patterns of expression in the developing forebrain 16, 20 . For Six3 or Six6 to be considered a direct regulator of Shh, their spatial and temporal expression profiles should overlap. In comparing Six3 and Six6 expression with SBE2-dependent Shh-lacZ reporter activity, we noted that in the ventral forebrain, from the level of the optic vesicles to the rostral extent of the diencephalon, Shh-lacZ was embedded within the Six3 and Six6 expression domains (Fig. 3) . Both Six3 and Six6 showed a broad distribution throughout the ventral portion of the anterior hypothalamus, whereas Shh-lacZ expression was restricted medially within the Six3 and Six6 domains (Fig. 3f-j) . Of note, the region of overlap between Shh-lacZ and Six3 and Six6 is precisely where mutant SBE2(T) reporter activity was diminished (Fig. 1c) .
We next determined whether Six6 is required to regulate Shh expression. Six6 À/À mouse embryos have reduced proliferation of retinal and pituitary progenitors but do not show overt signs of HPE 21 . Consistent with this milder phenotype, Shh expression was unaffected in the ventral forebrain of Six6 À/À embryos (Fig. 3k,l) . In contrast, Six3 À/À mouse embryos show severe forebrain truncations, including in rostral regions of the diencephalon 18 . Moreover, the combination of findings that mutations in SIX3 cause HPE in humans 17 and that mouse embryos carrying a knock-in allele of an HPE-causing point mutation in Six3 show reduced Shh expression in the forebrain 22 is consistent with an essential role for Six3 in the direct regulation of Shh transcription.
Our finding that the DNA sequence containing SBE2(C) functions as a Six3 and Six6 binding site raised the possibility that the SBE2(T) variant interferes with the recruitment of Six3 to this site. To test this hypothesis, we evaluated the affinity of Six3 for SBE2(C) compared to SBE2(T). We generated a dose-response curve by varying the amount of radiolabeled probe exposed to a constant amount of Six3 protein and quantifying band intensity as a measure of Six3-SBE2 complex formation. SBE2(C) consistently showed a stronger association with Six3 compared to SBE2(T) at all doses of probe tested (Fig. 4a,b) . Similar results were observed with Six6 (data not shown).
We also quantified the amount of radiolabeled probe displaced from Six3 in the presence of increasing amounts of unlabeled (cold) competitor. In the presence of 50-and 100-fold excess wild-type SBE2(C) unlabeled competitor, the majority (60% and 75%, respectively) of the radiolabeled SBE2(C) probe was displaced from Six3 (Fig. 4c, lanes 2-4, and Fig. 4d) . In comparison, when 50-and 100-fold excess SBE2(T) unlabeled competitor was introduced, significantly less (27% and 50%, respectively) of the radiolabled SBE2(C) probe was displaced from Six3 ( Fig. 4c lanes 2,6,7 and Fig. 4d ). We obtained similar results when we used SBE2(T) as the radiolabeled probe (data not shown). These results indicate that the SBE2(T) variant weakens the affinity of Six3 binding by approximately twofold in relation to SBE2(C) (Fig. 4b,d) .
We also confirmed Six3 binding to SBE2(C) in vivo by chromatin immunoprecipitation (ChIP). SBE2 was significantly enriched in Six3-bound chromatin isolated from forebrain compared to posterior trunk regions of E8.75 mouse embryos (Fig. 4e) . A control sequence, 6.5 kb downstream of SBE2, was not enriched in Six3-bound chromatin. The extent of Six3 binding to SBE2 is comparable to that of another Six3 target sequence identified in the Pax6 SIMO lens enhancer 23 (Fig. 4e) . Taken together, these data are consistent with our hypothesis that Six3 is a direct regulator of SBE2 activity, and that the SBE2(T) variant compromises the recruitment of Six3 and subsequent activation of Shh transcription. Although our data suggest that the SBE2(T) variant may cause HPE, formal proof of this claim must await the evaluation of mice carrying a targeted knock-in of SBE2(T) into the mouse genome.
Six3 functions as a context-dependent activator or repressor of target gene expression in the developing eye and forebrain 18, 19, [23] [24] [25] . In addition, Six3 promotes the proliferation of forebrain progenitors by antagonizing geminin, a DNA replication inhibitor 26 . This aspect of Six3 function is independent of its DNA-binding properties. Hence, the mechanism by which individuals carrying mutations in SIX3 develop HPE may be due to heightened geminin function, improper regulation of target gene expression, or both. To determine whether HPE-causing mutations in Six3 impair the ability of the mutant proteins to bind SBE2, we carried out EMSAs. COS-1 cell extracts expressing equivalent amounts of wild-type or mutant forms of mouse Six3 were incubated with radiolabeled SBE2(C) probe (Fig. 5a) . Three independent substitutions in the homeodomain either reduced (V250A) or prevented (R257P, R257W) Six3-SBE2 complex formation (Fig. 5a, lanes 2,3,5,7) . Unexpectedly, two of three substitutions in the Six domain also showed greatly reduced (V92G) or absent (H173P) Six3-SBE2 complex formation (Fig. 5a, lanes 2,4,6 ). Only the F88E substitution in the Groucho interaction domain retained the ability to bind SBE2 (Fig. 5a, lanes 2,8) . The Six3 mutants that failed to bind SBE2(C) were also impaired in their ability to stimulate SBE2(C)-lacZ expression in Cos-1 cells (Fig. 5b) . Similarly, Six3-dependent activation of SBE2(T)-lacZ expression in COS-1 cells was significantly reduced compared to that of SBE2(C)-lacZ (Fig. 5c) . How mutations affecting the Six domain interfere with the DNAbinding properties of Six3 is unclear, but may indicate a previously unappreciated interaction between the Six domain and the homeodomain. On the basis of these results, we deem it likely that the mechanism by which HPE manifests in individuals carrying point mutations in SIX3 is due, in part, to a failure in the binding of SHH regulatory sequences and subsequent activation of SHH transcription in the ventral forebrain.
Results from this study provide a better understanding of the transcriptional control mechanisms regulating SHH expression during normal forebrain development and in the pathogenesis of HPE. Our data suggest that Six3 is a direct regulator of Shh expression in the anterior diencephalon. Moreover, the approaches taken in assigning function to a putative HPE-causing variant in a remote SHH regulatory element should be generally applicable for studying the growing number of rare, as well as common, regulatory SNPs that modulate gene expression in normal and disease states [27] [28] [29] .
METHODS
Sequence analysis of SBE2. We screened genomic DNA from 474 individuals with sporadic or familial HPE registered at the National Institutes of Health (NIH) and 450 normal controls for mutations in SBE2. Genomic DNA was extracted from either lymphocytes or established lymphoblastoid cell lines by routine methods. All samples were obtained by informed consent according to the guidelines of the National Human Genome Research Institute Institutional Review Board.
For PCR amplification and direct sequencing, we designed one pair of primers (FBE) to amplify the 1.1-kb SBE2 region (Supplementary Table 2 online). Sequencing was done using five internal primers (available upon request), allowing sequence reads of both strands. Amplification of genomic DNA was done in a 35 ml reaction volume, using 60-100 ng DNA template, 3.5 ml of 10Â PCR Amplification Buffer (Invitrogen), 1.75 ml of PCR Enhancer solution (Invitrogen), 1 ml of 50 mM MgSO 4 (Invitrogen), 0.3 ml of 25 mM dNTP stock mixture (Amersham Biosciences), 1 ml of each 20 pmol primer (Invitrogen) and 0.5ml of AmpliTaq 5U/ml (Applied Biosystems). The PCR cycling parameters used for amplification were 95 1C for 4 min followed by 30 cycles of 95 1C for 30 s, 60 1C for 30 s and 72 1C for 1 min, and a final extension of 72 1C for 7 min. We used the Big Dye terminator cycle sequencing kit 3.1 (Applied Biosystems) for direct DNA sequencing and analyzed the reactions on an ABI 3100 Genetic Analyzer.
DNA affinity-capture assay. We preincubated 500 ml of brain nuclear extracts (2 mg/ml) prepared from adult mice (Sigma NuCLEAR Extraction kit) for 20 min at 4 1C in 300 ml of binding buffer (10 mM Tris-Cl pH 7.4, 50 mM NaCl, 1 mM EDTA, 1 mM DTT and 5% glycerol), 25 ml of dIdC (200 ng/ml), 25 ml of BSA (1mg/ml) and 550 ml of H 2 O. The extracts were precleaned with 100 ml of a 50% slurry of streptavidin agarose beads (Invitrogen) at 4 1C for 30 min with rotation, centrifuged at high speed for 30 s and transferred (supernatant) into a new tube. A double-stranded DNA oligonucleotide (18-mer) overlapping a conserved 10-bp segment of SBE2 (Supplementary Table 2 ) was synthesized with a terminal 5¢ biotin modification (Invitrogen) and incubated with the brain nuclear extracts for 3 h at 4 1C with rotation. We also used an SBE2 mismatch oligo (Supplementary Table 2 ) in a parallel experiment as a negative control for nonspecific binding proteins. We added 50 ml of a 50% slurry of streptavidin agarose beads to the mixture for 30 min at 4 1C with rotation. The beads were centrifuged, washed twice in binding buffer, twice in wash buffer (10 mM Tris-Cl pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1% Nonidet P-40) and twice in PBS. The beads were stored at À20 1C until trypsin digestion and subjected to reversed-phase liquid chromatography/tandem mass spectrometry analysis at the University of Pennsylvania proteomics core facility. The raw mass spectrometry data were submitted to Bioworks Browser (Thermo Electron) and batch searched through Turbo-SEQUEST against an indexed mouse RefSeq database (version updated December 2004; details available upon request).
Electromobility shift assays (EMSA). We transfected pCDNA3-Flag, pCDNA3-Six3-Flag, pCDNA3-(M1-6)-Six3-Flag and pCDNA3-Six6-Flag plasmids into COS-1 cells using FuGENE 6 transfection reagent (Roche). After 48 h, whole-cell lysates were prepared in a buffer containing 50 mM Tris-HCl pH 7.4, 1 mM EDTA, 1 mM DTT, protease inhibitor cocktail and 25% glycerol. For EMSA, we incubated 10 mg of protein from the cell lysates for 10 min at room temperature (25 1C) in a DNA-binding buffer containing 10 mM TrisHCl pH 7.4, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 5% glycerol, 200 ng poly(dI-dC) and 1 mg BSA in the presence or absence of competitor doublestranded oligonucleotides. After 0.1 ng (5 Â 10 4 to 10 Â 10 4 c.p.m.) of probe was added to the mixture, incubation was continued for an additional 20 min. Supershifts were done by incubating protein-DNA mixtures with 0.5 ml of mouse monoclonal antibody to Flag M2 (F3165; Sigma-Aldrich), or rabbit polyclonal antibody to Six3 (G. Oliver, St. Jude Children's Hospital) for 5 min before gel loading. We separated protein-bound DNA complex from free probe on a 6.5% acrylamide gel run in 1Â TBE (Tris-borate-EDTA) buffer. The nucleotide sequences of the sense strand of probes and competitors are listed in Supplementary Table 2 . Competitive EMSAs were done by incubating protein-DNA complexes with 50, 100 or 200 molar excess of cold probe. After overnight exposure, autoradiographs were scanned and the intensity of individual bands corresponding to the protein-DNA complex of interest was quantified using NIH ImageJ. Values were plotted as the ratio (percentage) of band intensities in the presence and absence of specific competitor and compared using the Student's t-test.
Transient transfection and dual reporter assay. We seeded COS-1 cells at 50-70% confluence and transfected them using Fugene 6 (Roche Applied Science) according to the manufacturer's instructions. We mixed 20 ng of pRL-TK vector (Promega), which contains the Renilla luciferase gene as a transfection efficiency control, and 500 ng of SBE2(C) or SBE2(T) LacZ reporter plasmids with 125 ng of empty pCMV, pCMV-Six3, or pCMV-mutant Six3 (M1-M6). Lysates were prepared 36 h after transfection by adding 100 ml of lysis solution (Dual-Light System; Applied Biosystems). We determined b-galactosidase activity by the accumulated product of Galacton-Plus substrate reaction (Applied Biosystems), and normalized it to that produced by Renilla luciferase. Enhancer activity was expressed as fold induction relative to that of cells transfected with the empty pCMV vector. We did at least three independent experiments for each construct.
Chromatin immunoprecipitation. The chromatin immunoprecipitation (ChIP) assay followed a modified version of a previously described protocol 30 . Briefly, pooled embryos at the 13-to 17-somite stage were fixed with 1% formaldehyde for 15 min with shaking. After a 5 min incubation with 100 mM glycine, heads and trunks were separated and disrupted in lysis buffer (20 mM Tris-HCl pH 7.5, 1% Triton X-100, 1 mM EDTA) and protease inhibitor cocktail (Sigma) by passing through 30G needles. Chromatin was sonicated and diluted with 20 mM Tris-HCl pH 7.5, 140 mM NaCl, 0.5% Triton X-100, and protease inhibitor cocktail. After preclearing with protein A agarose beads (Upstate), the chromatin was incubated overnight with 3 ml of antibody to Six3 (Rockland) or antibody to IgG (Santacruz), followed by incubation with protein A agarose beads, and washed with 20 mM Tris-HCl pH 7.5, 140 mM NaCl and 0.5% Triton X-100. After elution with 20 mM Tris-HCl pH 7.5, 10 mM EDTA and 1% SDS and decrosslinking, DNA was purified with QIAquick kit (Qiagen) and subject to quantitative PCR (QPCR) using the primers listed in Supplementary Table 2. QPCR was done using Brilliant SYBR Green QPCR Master Mix (Stratagene) on an Mx4000 instrument (Stratagene). Each reaction contained 0.6 ml of a 1 in 1,600 diluted reference dye, 2 ml of chromatin DNA, 1 ml of 2 uM primer A, 1 ml of 2 mM primer B and 10 ml of 2Â Master Mix in a final reaction volume of 20 ml. PCRs were amplified for 1 cycle at 95 1C for 10 min and 40 cycles at 95 1C for 30 s, 57 1C for 1 min and 72 1C for 30 s. PCRs of three independent replicates were each done in triplicate. We used differences in threshold cycle (Ct) number to quantify relative amounts of target DNA template. We normalized Ct number for each chromatin sample to Ct number for input PCR. Relative enrichment of target chromatin DNA was determined by 2 -(Ct1-Ct2) , assuming that one Ct number difference represents a twofold difference in the amount of starting template.
Plasmid construction. We cloned the SBE2 reporter constructs into a vector containing the Shh minimal promoter, lacZ gene and SV40 poly(A) signal. A construct harboring a deletion of the 10-bp sequence (AACTCATTTT) from human SBE2 was generated by ligating two PCR products flanking the region of interest that were amplified with primer pairs listed in Supplementary Table 2 . The cloning of full-length human Six3 and Six6 cDNAs into the pCDNA3-Flag expression vector was described previously 20 .
Production and genotyping of transgenic mice. Transgenes were prepared for microinjection as described 11 . Transient transgenic embryos were generated by pronuclear injection into fertilized eggs derived from the (BL6 Â SJL) F 1 mouse strain (Jackson Laboratories). The generation of Six6 À/À embryos has been described previously 21 .
Whole-mount b-galactosidase staining and in situ hybridization. We detected b-galactosidase activity in whole-mount embryos by using X-gal (Sigma) or salmon-gal (Biosynth) as substrates. Whole-mount RNA in situ hybridization was done using digoxygenin-UTP-labeled riboprobes against Shh, Six3 and Six6 according to a previously described protocol 11 . For doublelabeling experiments, embryos were initially fixed for 60 min in 4% paraformaldehyde, stained in salmon-gal substrate for 2 h then postfixed overnight in 4% paraformaldehyde. Whole-mount in situ hybridization was then done essentially as described 11 . We photographed stained embryos after dehydration in methanol and clearing in a 1:1 solution of benzyl alcohol and benzyl benzoate. Representative embryos were rehydrated, sunk in 30% sucrose overnight, embedded and frozen in O.C.T. compound (Tissue Tek) and sectioned at 20 mm on a cryostat.
URLs. TRANSFAC, http://helixweb.nih.gov/biobase/.
Note: Supplementary information is available on the Nature Genetics website.
